Interictal serum S-100B protein levels in intractable epilepsy: A case-control study

Neuroscience Letters

Volumn 558, Issue , 2014, Pages 58-61

  Calik, Mustafa ^a   Abuhandan, Mahmut ^a   Kandemir, Hasan ^a   Güzel, Bülent ^a   Solmaz, Abdullah ^a   Celik, Hakim ^a   Taskin, Abdullah ^a   Iscan, Akin ^b  

^a HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

Biomarker; Childhood; Focal intractable epilepsy; S 100B

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PROTEIN S100B; TOPIRAMATE; VALPROIC ACID;

ANTICONVULSANT THERAPY; ARTICLE; CASE CONTROL STUDY; CHEMILUMINESCENCE IMMUNOASSAY; CHILD; CHILDHOOD ABSENCE EPILEPSY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; GRAND MAL EPILEPSY; HUMAN; INTRACTABLE EPILEPSY; MALE; MYOCLONUS EPILEPSY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TEMPORAL LOBE EPILEPSY; TONIC CLONIC SEIZURE;

BIOMARKER; CHILDHOOD; FOCAL INTRACTABLE EPILEPSY; S-100B;

ADOLESCENT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; EPILEPSY; FEMALE; HUMANS; MALE; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; TREATMENT FAILURE;

EID: 84888414811     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.10.040     Document Type: Article

References (24)

1. Ahlemeyer B., Beier H., Semkova I., Schaper C., Krieglstein J. S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702. Brain Res. 2000, 858(1):121-128.
2. Arts W.F., Brouwer O.F., Peters A.C., Stroink H., Peeters E.A., Schmitz P.I., Donselaar C.A., Geerts A.T. Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood. Brain 2004, 127(8):1774-1784.
3. Atici Y., Alehan F., Sezer T., Tuygun N., Haberal A., Yazici A.C., Karacan C.D. Serum S100B levels in children with simple febrile seizures. Seizure 2012, 21(3):175-177.
4. Briellmann R.S., Kalnins R.M., Berkovic S.F., Jackson G.D. Hippocampal pathology in refractory temporal lobe epilepsy: t2-weighted signal change reflects dentate gliosis. Neurology 2002, 58(2):134-136.
5. Büttner T., Lack B., Jäger M., Wünsche W., Kuhn W., Müller T., Przuntek H., Postert T. Serum levels of neuron-specific enolase and s-100 protein after single tonic-clonic seizures. J. Neurol. 1999, 246(6):459-461.
6. Calik M., Abuhandan M., Sonmezler A., Kandemir H., Oz I., Taskin A., Selek S., Iscan A. Elevated serum S-100B levels in children with temporal lobe epilepsy. Seizure 2013, 22(2):99-102.
7. Chaves M.L., Camozzato A.L., Ferreira E.D., Piazenski I., Kochhann R., Dall'Igna O., Mazzini G.S., Souza D.O., Portela L.V. Serum levels of S100B and NSE proteins in Alzheimer's disease patients. J. Neuroinflam. 2010, 27(7):6.
8. Choi J., Nordli D.R., Alden T.D., DiPatri A., Laux L., Kelley K., Rosenow J., Schuele S.U., Rajaram V., Koh S. Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J. Neuroinflam. 2009, 19(6):38.
9. da Rocha A.B., Schneider R.F., de Freitas G.R., André C., Grivicich I., Zanoni C., Fossá A., Gehrke J.T., Pereira Jotz G., Kaufmann M., Simon D., Regner A. Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males. Clin. Chem. Lab. Med. 2006, 44(10):1234-1242.
10. Forsgren L. Incidence and prevalence. Epilepsy in children 2004, 21-25. Taylor & Francis group, London. S.J. Wallace, K. Farrell (Eds.).
11. Gazzolo D., Michetti F., Bruschettini M., Marchese N., Lituania M., Mangraviti S., Pedrazzi E., Bruschettini P. Pediatric concentrations of S100B protein in blood: age-and sexrelated changes. Clin. Chem. 2003, 49(6):967-970.
12. Gazzolo D., Abella R., Marinoni E., di Iorio R., Li Volti G., Galvano F., Frigiola A., Temporini F., Moresco L., Colivicchi M., Sabatini M., Ricotti A., Strozzi M.C., Crivelli S., Risso F.M., Sannia A., Florio P. New markers of neonatal neurology. J. Matern. Fetal Neonatal Med. 2009, 22(Suppl. 3):57-66.
13. Geyer C., Ulrich A., Gräfe G., Stach B., Till H. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury. J. Neurosurg. Pediatr. 2009, 4(4):339-344.
14. Griffin W.S., Yeralan O., Sheng J.G., Boop F.A., Mrak R.E., Rovnaghi C.R., Burnett B.A., Feoktistova A., Van Eldik L.J. Overexpression of the neurotrophic cytokine S100 beta in human temporal lobe epilepsy. J. Neurochem. 1995, 65(1):228-233.
15. Leutmezer F., Wagner O., Baumgartner C. Serum S-100 protein is not a suitable seizure marker in temporal lobe epilepsy. Epilepsia 2002, 43(10):1172-1174.
16. Lu C., Li J., Sun W., Feng L., Li L., Liu A., Li J., Mao W., Wei H., Gao L., Zhang X., Huang Z., Meng X., Wang Y. Elevated plasma S100B concentration is associated with mesial temporal lobe epilepsy in Han Chinese: a case-control study. Neurosci. Lett. 2010, 484(2):139-142.
17. Marchi N., Cavaglia M., Fazio V., Bhudia S., Hallene K., Jangiro D. Peripheral markers of blood-brain barrier damage. Clin. Chim. Acta 2004, 342(1-2):1-12.
18. Mikkonen K., Pekkala N., Pokka T., Romner B., Uhari M., Rantala H. S100B proteins in febrile seizures. Seizure 2012, 21(2):144-146.
19. Ortinski P.I., Dong J., Mungenast A., Yue C., Takano H., Watson D.J., Haydon P.G., Coulter D.A. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat. Neurosci. 2010, 13(5):584-591.
20. Palmio J., Keränen T., Alapirtti T., Hulkkonen J., Mäkinen R., Holm P., Suhonen J., Peltola J. Elevated serum neuron-specific enolase in patients with temporal lobe epilepsy: a video-EEG study. Epilepsy Res. 2008, 81(2-3):155-160.
21. Portela L.V., Tort A.B., Walz R., Bianchin M., Trevisol-Bittencourt P.C., Wille P.R., Cardoso R.C., Ishida M.M., vonWangenheim A., Grisard E.C., Steindel M., Gonçalves C.A., Souza D.O. Interictal serum S100B levels in chronic neurocysticercosis and idiopathic epilepsy. Acta Neurol. Scand. 2003, 108(6):424-427.
22. Rothermundt M., Peters M., Prehn J.H., Arolt V. S100B in brain damage and neurodegeneration. Microsc. Res. Tech. 2003, 60(6):614-632.
23. Schulpis K.H., Margeli A., Akalestos A., Vlachos G.D., Partsinevelos G.A., Papastamataki M., Antsaklis A., Papassotiriou I. Effects of mode of delivery on maternal-neonatal plasma antioxidant status and on protein S100B serum concentrations. Scand. J. Clin. Lab. Invest. 2006, 66(8):733-742.
24. Steinhoff B., Tumani H., Otto M., Mursch K., Wiltfang J., Herrendorf G., Bittermann H.J., Felgenhauer K., Paulus W., Markakis E. Cisternal S-100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy. Epilepsy Res. 1999, 36(1):75-82.